Quantitative structure/property relationship analysis of Caco‐2 permeability using a genetic algorithm‐based partial least squares method

Caco‐2 cell monolayers are widely used systems for predicting human intestinal absorption. This study was carried out to develop a quantitative structure–property relationship (QSPR) model of Caco‐2 permeability using a novel genetic algorithm‐based partial least squares (GA‐PLS) method. The Caco‐2...

Full description

Saved in:
Bibliographic Details
Published inJournal of pharmaceutical sciences Vol. 91; no. 10; pp. 2230 - 2239
Main Authors Yamashita, Fumiyoshi, Wanchana, Suchada, Hashida, Mitsuru
Format Journal Article
LanguageEnglish
Published New York Elsevier Inc 01.10.2002
Wiley Subscription Services, Inc., A Wiley Company
Wiley
American Pharmaceutical Association
Subjects
Online AccessGet full text
ISSN0022-3549
1520-6017
DOI10.1002/jps.10214

Cover

More Information
Summary:Caco‐2 cell monolayers are widely used systems for predicting human intestinal absorption. This study was carried out to develop a quantitative structure–property relationship (QSPR) model of Caco‐2 permeability using a novel genetic algorithm‐based partial least squares (GA‐PLS) method. The Caco‐2 permeability data for 73 compounds were taken from the literature. Molconn‐Z descriptors of these compounds were calculated as molecular descriptors, and the optimal subset of the descriptors was explored by GA‐PLS analysis. A fitness function considering both goodness‐of‐fit to the training data and predictability of the testing data was adopted throughout the genetic algorithm‐driven optimization procedure. The final PLS model consisting of 24 descriptors gave a correlation coefficient (r) of 0.886 for the entire dataset and a predictive correlation coefficient (rpred) of 0.825 that was evaluated by a leave‐some‐out cross‐validation procedure. Thus, the GA‐PLS analysis proved to be a reasonable QSPR modeling approach for predicting Caco‐2 permeability. © 2002 Wiley‐Liss Inc. and the American Pharmaceutical Association J Pharm Sci 91:2230–2239, 2002
Bibliography:ArticleID:JPS10214
istex:2D1A50A5D83FF6E16449C4FC3E7951560C647226
ark:/67375/WNG-6H6R7L6W-K
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-3549
1520-6017
DOI:10.1002/jps.10214